Cercar
01/10/2023
On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome
Huerta A., Arjona E., Portoles J., Lopez-Sanchez P., Cavero T., Fernandez-Cusicanqui J., Blasco M., Cabello V., Calvo N., Diaz M., Herrero-Goñi M., Aguirre M., Elías S., Alcaide M.P., Ramos N., Sellares J., Rodríguez de Córdoba S.. On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome. KIDNEY INTERNATIONAL. 2023; 104(4)DOI:10.1016/j.kint.2023.07.020. PMID:37567446. IF:14.800(Q1/1D).
29/09/2023
Treatment and long-term outcome in primary nephrogenic diabetes insipidus
Lopez-Garcia, SC, Downie, ML, Kim, JS, Boyer, O, Walsh, SB, Nijenhuis, T, Papizh, S, Yadav, P, Reynolds, B, Decramer, S, Besouw, M, Carrascosa, MP, La Scola, C, Trepiccione, F, Ariceta, G, Hummel, A, Dossier, C, Sayer, JA, Konrad, M, Keijzer-Veen, MG, Awan, A, Basu, B, Chauveau, D, Madariaga, L, Koster-Kamphuis, L, Furlano, M, Zacchia, M, Marzuillo, P, Tse, Y, Dursun, I, Pinarbasi, AS, Tramma, D, Hoorn, EJ, Gokce, I, Nicholls, K, Eid, LA, Sartz, L, Riordan, M, Hooman, N, Printza, N, Bonny, O, Sancho, PA, Schild, R, Sinha, R, Guarino, S, Jimenez, VM, Peña, LR, Belge, H, Devuyst, O, Wlodkowski, T, Emma, F, Levtchenko, E, Knoers, NVAM, Bichet, DG, Schaefer, F, Kleta, R, European NDI Consortium, Bockenhauer, D. Treatment and long-term outcome in primary nephrogenic diabetes insipidus. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2023; 38(10)DOI:10.1093/ndt/gfaa243. PMID:33367818. IF:4.800(Q1/2D).
26/09/2023
Polygenic risk of major depressive disorder as a risk factor for venous thromboembolism.
Ward J, Le NQ, Suryakant S, Brody JA, Amouyel P, Boland A, Bown R, Cullen B, Debette S, Deleuze JF, Emmerich J, Graham N, Germain M, Anderson JJ, Pell JP, Lyall DM, Lyall LM, Smith DJ, Wiggins KL, Soria JM, Souto JC, Morange PE, Smith NL, Trégouët DA, Sabater-Lleal M, Strawbridge RJ. Polygenic risk of major depressive disorder as a risk factor for venous thromboembolism.. Blood Advances. 2023; 7(18)DOI:10.1182/bloodadvances.2023010562. PMID:37399490. IF:7.400(Q1/2D).
26/09/2023
Immune restoration with ibrutinib plus venetoclax in first-line chronic lymphocytic leukemia: the phase 2 CAPTIVATE study.
Moreno C, Solman IG, Tam CS, Grigg A, Scarfò L, Kipps TJ, Srinivasan S, Mali RS, Zhou C, Dean JP, Szafer-Glusman E, Choi M. Immune restoration with ibrutinib plus venetoclax in first-line chronic lymphocytic leukemia: the phase 2 CAPTIVATE study.. Blood Advances. 2023; 7(18)DOI:10.1182/bloodadvances.2023010236. PMID:37315225. IF:7.400(Q1/2D).
25/09/2023
Burden of refractory and unexplained chronic cough on patients' lives: a cohort study.
Puente-Maestu L, Dávila I, Quirce S, Crespo-Lessmann A, Martínez-Moragón E, Sola J, Nieto ML, González-Barcala FJ, Cea-Calvo L, Sánchez-Jareño M, Rivas-Pardinas C, Domingo C. Burden of refractory and unexplained chronic cough on patients' lives: a cohort study.. Erj Open Research. 2023; 9(5)DOI:10.1183/23120541.00425-2023. PMID:37753282. IF:4.300(Q1/3D).
24/09/2023
Research on missed nursing care during the COVID-19 pandemic: A scoping review.
Zabaleta-Del-Olmo E, Santesmases-Masana R, Martín-Payo R, Romero-Collado À, Zamora-Sánchez JJ, Urpí-Fernández AM, Gonzalez-Del-Rio M, Lumillo-Gutiérrez I, Sastre-Rus M, Jodar-Fernández L, Hernández-Martínez-Esparza E. Research on missed nursing care during the COVID-19 pandemic: A scoping review.. Worldviews on Evidence-Based Nursing. 2023; 20(6)DOI:10.1111/wvn.12682. PMID:37743584. IF:3.400(Q1/1D).
24/09/2023
Frailty and mortality: Utility of Frail-VIG index in ED short-stay units for older adults.
Blázquez-Andión M, Montiel-Dacosta JA, Rizzi-Bordigoni M, Acosta-Mejuto B, Moliné-Pareja A, Ris-Romeu J, Puig-Campmany M. Frailty and mortality: Utility of Frail-VIG index in ED short-stay units for older adults.. ARCHIVES OF GERONTOLOGY AND GERIATRICS. 2023; 115DOI:10.1016/j.archger.2023.105208. PMID:37774490. IF:3.500(Q2/4D).
23/09/2023
Clinical characteristics and outcome of amaurosis fugax due to transient retinal ischemia: Results from a contemporary cohort.
Martinez-Viguera A, Xuclà-Ferrarons T, Collet R, Olmedo-Saura G, Martí-Fàbregas J, Izquierdo A, Martínez-Domeño A, Prats-Sánchez L, Guasch-Jiménez M, Guisado-Alonso D, Ramos-Pachón A, Camps-Renom P. Clinical characteristics and outcome of amaurosis fugax due to transient retinal ischemia: Results from a contemporary cohort.. Journal of Stroke & Cerebrovascular Diseases. 2023; 32(11)DOI:10.1016/j.jstrokecerebrovasdis.2023.107335. PMID:37748428. IF:2.000(Q3/6D).